Ananya Raysoni
Associate Director - Genome Editing at Novo Nordisk | Greater Boston, United States
Ananya Raysoni’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
Ananya Raysoni serves as an Associate Director of Genome Editing at Novo Nordisk, driving biotechnology initiatives across the Greater Boston region. Her technical expertise covers early drug development and RNA therapeutics, complemented by formal training from the University of Wisconsin-Madison. Within the organization, she aligns with the company’s broader mission to engineer advanced treatments that prevent, treat, and potentially cure major chronic conditions.
BEST APPROACH TO REACH Ananya Raysoni
Leverage their high-confidence personal contact signals by initiating outreach through a targeted LinkedIn message or personal email that references recent advancements in genome editing and early-stage therapeutic pipelines at Novo Nordisk.
Associate Director - Genome Editing at Novo Nordisk in July 2025 - Present
Associate Director at Tessera Therapeutics in January 2024 - July 2025
Senior Scientist at Tessera Therapeutics in July 2022 - December 2023
Scientist II at Tessera Therapeutics in April 2021 - June 2022
Scientist at Tessera Therapeutics in February 2020 - April 2021
Broad Affiliate at Broad Institute of MIT and Harvard in November 2017 - November 2019
Postdoctoral Research Fellow at Harvard Medical School and Massachusetts General Hospital in August 2017 - November 2019
PHD Candidate at University of Wisconsin-Madison in April 2011 - June 2017
Teaching Assistant at University of Wisconsin-Madison in September 2012 - December 2012
PhD Candidate (rotation period) at University of Wisconsin-Madison in August 2010 - March 2011
Undergraduate Research Assistant at University of Rochester Medical Center in September 2009 - May 2010
Teaching Assistant at University of Rochester in September 2007 - December 2009
Summer Research Trainee at Saha Institute of Nuclear Physics in June 2009 - July 2009
Undergraduate Research Assistant at University of Rochester in September 2007 - July 2008
Summer Research Trainee at Indian Institute of Chemical Biology in June 2007 - July 2007
Lab Technician at University of Rochester in September 2006 - May 2007
Research Trainee at Indian Institute of Chemical Biology in June 2006 - August 2006
University of Wisconsin-Madison, Doctor of Philosophy (PhD), October 2026
University of Rochester, Bachelor of Science (BS), October 2026
Calcutta International School, Middle & High School, October 1999 to October 2026
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
Discover more about Novo Nordisk
Doctor of Pharmacy | Skincare Consultant
Drug Safety Associate - II at Novo Nordisk
(December 2021 – Present)
Project Vice President
People& Organization Manager at Novo Nordisk
(April 2021 – Present)
ACCA Part Qualified Accountant | Accounts Payable | Finance Manager | Financial Analyst
Analista financeiro at Novo Nordisk
(October 2023 – Present)
Senior Medical Representative at Novo Nordisk
Senior Medical Sales Representative at Novo Nordisk
(August 2025 – Present)
Estagiário de Comunicação na Novo Nordisk | Comunicação | Redator | Jornalista esportivo | Produção Multimídia | Mídias Digitais
Redator esportivo at Mais que 90 Minutos
(March 2024 – Present)
Sr Clinical Research Associate • RBQM Advocate • Innovation in Clinical Trials
RBQM and Digital Transformation Specialist at Novo Nordisk
(November 2023 – Present)
What is Ananya Ray-soni email address?
Email Ananya Ray-soni at [email protected] and [email protected]. This email is the most updated Ananya Ray-soni's email found in 2026.
How to contact Ananya Ray-soni?
To contact Ananya Ray-soni send an email to [email protected] or [email protected]. (updated on September 12, 2025)
What company does Ananya Raysoni work for?
Ananya Raysoni works for Novo Nordisk.
What is Ananya Raysoni's role at Novo Nordisk?
Ananya Raysoni is Associate Director - Genome Editing
What industry does Ananya Raysoni work in?
Ananya Raysoni works in the Biotechnology industry.
